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Introduction {#s1}
============

Vitamin B deficiency is common worldwide and may lead to psychiatric symptoms ([@B1]--[@B4]). For example, meta-analyses have shown that patients with schizophrenia or first-episode psychosis have lower folate (vitamin B~9~) levels than their healthy counterparts ([@B4], [@B5]). Moreover, vitamin therapy can effectively alleviate symptoms in a subgroup of patients with schizophrenia ([@B3], [@B6]--[@B8]). However, the epidemiology of vitamin B deficiency in patients with active mental symptoms requiring immediate hospitalization has rarely been examined.

In a psychiatric emergency, psychiatrists should promptly distinguish treatable patients with altered mental status due to a physical disease from patients with an authentic mental disorder (International Statistical Classification of Diseases and Related Health Problems-10, ICD-10 code: F2-9). However, vitamin deficiency testing is very costly (around 60 dollars for each measurement of vitamin B~1~ (vitB~1~), vitamin B~12~ (vitB~12~), or folate in the U.S.; 15--25 dollars for each test in Japan) and usually requires at least two days. Therefore, an efficient, cost-effective method of predicting vitamin B deficiency is needed.

Although several studies have applied machine-learning to the prediction of diagnosis or treatment outcomes ([@B9]--[@B11]), no study using machine-learning has focused on vitamin B deficiencies. We herein explore whether vitB~1~, vitB~12~, and folate deficiencies can be predicted using a machine-learning classifier from patient characteristics and routine blood test results obtained within one hour based on a large cohort of patients requiring urgent psychiatric hospitalization.

Methods {#s2}
=======

Medical Chart Review {#s2_1}
--------------------

We reviewed consecutive patients admitted to the Department of Neuropsychiatry at Tokyo Metropolitan Tama Medical Center, one of the biggest psychiatric tertiary-care centers in Japan, between September 2015 and August 2017 under the urgent involuntary hospitalization law, which requires the immediate psychiatric hospitalization of patients at imminent risk of seriously harming themselves or others. The necessity of hospitalization was judged by designated mental health specialists. There were no exclusion criteria. The patient characteristics, ICD-10 codes, and laboratory data were gathered retrospectively.

Since the reference ranges for vitB~1~, vitB~12~, and folate are 70--180 nmol/L (30--77 ng/mL), 180--914 ng/L, and \>4.0 μg/L, respectively ([@B12]), a deficiency of the nutrients was defined as \<30 ng/mL, \<180 ng/L, and \<4.0 μg/L, respectively, unless otherwise stated. The odds ratios of each deficiency in each ICD-10 code were calculated assuming binomial distribution.

Classifiers and Statistics {#s2_2}
--------------------------

We compared four types of standard machine-learning classifiers: k-nearest neighbors, logistic regression, support vector machine, and random forest. Each type of classifier was trained to predict the deficiency of each substance from age, sex, and 29 routine blood variables (described with values in the *Results* section). For developing the models, any missing values were replaced using the mean. The classifiers were trained using the dataset populated in the period from September 2015 to December 2016 (the "Training set"). First, except for logistic regression, we optimized the hyperparameters of the classifier by selecting the best combination of hyperparameters that maximized the \"5-fold cross validation\" accuracy, among many combinations within appropriate ranges. The cross-validation accuracy was computed as follows: in one session, the classifiers were trained using 80% of the training set and evaluated on the withheld 20% of the training set. This session was performed five times so that every data would be withheld once. The accuracies were finally averaged across sessions to yield the cross-validation accuracy. By incorporating this process, the classifiers were generalized to unseen data (Graphical method is shown in [**Figure 1**](#f1){ref-type="fig"}).

![Graphical illustration of method of machine-learning.](fpsyt-10-01029-g001){#f1}

Using the optimized hyperparameters, the classifiers were then validated using data collected from January 2017 through August 2017 (the "Validation set"). We report the classification performance on the validation set in the *Results* section unless otherwise stated.

We quantified the sensitivity, specificity, and accuracy (defined as the average of the sensitivity and the specificity on the optimal operating point) using receiver operating characteristic curves (ROCs). We also quantified the 95% confidence interval of the area under the ROCs (AUCs) and accuracy using 1000-times bootstrapping.

When investigating the Gini importance and the partial dependency ([@B13]), we retrained the classifiers using all datasets. All data analyses were performed using Python (2.7.10) with the Scikit-learn package (0.19.0) and R (3.4.2) with the edarf package (1.1.1) and pROC package (1.15.3).

Robustness Verification {#s2_3}
-----------------------

We verified the robustness of the prediction performances by three independent approaches. First, we compared the following two prediction performances: random forest classifiers trained and validated using the dataset from the F2 population, and random forest classifiers trained and validated using the dataset from the non-F2 population.

Second, we compared the prediction performances of several random forest classifiers trained and validated using the dataset where different cut-off values were used to define the vitamin deficiency. We chose other two cut-off values for each vitamin based on previous reports ([@B14]--[@B16]), as well as pre-defined cut-off values (see also *Medical Chart Review* section).

Third, we trained and validated other random forest classifiers where the dataset was split in a different way. Here, the training set consisted of data between 31 January 2016 and August 2017 and the validation set consisted of data between September 2015 and 31 January 2016, so that the sample sizes of the training and validation sets were equal to those in the original split.

Subsampling Analysis {#s2_4}
--------------------

We also examined the relationship between the dataset size and the generalization performance ([@B17]). In this analysis, we trained the random forest classifiers using X% of the training set (X = 30, 35, 40, ..., 95, and 100), and validated them using the validation set. The hyperparameters were identical to those used in the previous section. To remove sampling bias, this procedure was repeated 100 times for each value of X, where the training dataset was sampled randomly for each repetition. This results in obtaining 100 AUC scores for each X and for each vitamin. We plotted the AUC scores (averaged across the 100 repetition) versus X for each vitamin, then the curve was fit with the following saturating function using Levenberg-Marquardt algorithm implemented as "curve_fit" function in the Scipy package (0.19.0).
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where *Y* is the AUC score, and *a* and *b* are the parameters to fit. Note that *Y* →*a*+0.5 as *X* →*∞* and *Y* = 0.5 as *X* = 0.

Ethical Considerations {#s2_5}
----------------------

Informed consent was obtained from participants using an optout form on the website. The study protocol was approved by the Research Ethics Committee, Tokyo Metropolitan Tama Medical Center (Approval number: 28-8). The study complied with the Declaration of Helsinki and the STROBE statement.

Results {#s3}
=======

Eligible Patients {#s3_1}
-----------------

During the 2-year study period, 497 consecutive patients (496 were Asian) were enrolled. The mean age (standard deviation, SD) was 42.3 (±15.4) years, and 228 patients (45.9%) were women. F2 (Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders) was diagnosed in over 60% of the patients. The ICD-10 codes of the patients and the number of deficiencies at several cut-off values for vitB~1~, vitB~12~, and folate are shown in [**Table 1**](#T1){ref-type="table"}. According to the predefined cut-off values ([@B12]), 112 (22.5%), 80 (16.1%), and 72 (14.5%) patients exhibited a deficiency of vitB~1~ (\<30 ng/mL), vitB~12~ (\<180 ng/L), and folate (\<4.0 μg/L), respectively. Vitamin B deficiencies in sub-groups are shown in [**Table 2**](#T2){ref-type="table"}. A summary of the full dataset is shown in [**Table 3**](#T3){ref-type="table"}. Detailed information (sub-datasets) is shown in [**Supplementary Tables 1--3**](#SM1){ref-type="supplementary-material"} online. Histograms of vitB~1~, vitB~12~, and folate values are shown in [**Figures 2A--C**](#f2){ref-type="fig"}.

###### 

Patient distribution data (n = 497).

  Age                 Sex                                 Race                      ICD-10 code   VitB~1~ \[ng/mL\]   VitB~12~ \[ng/L\]   Folate \[μg/L\]                                                                                                          
  ------------------- ----------------------------------- -------------------- ---- ------------- ------------------- ------------------- ----------------- ----- ----- ----- ----- ----- ----- ------ ------ -------- ------- --------- ------- ------- --------- -------
  42.3 (15.4) years   Woman 228 (45.9%) Man 269 (54.1%)   Asian 496 Others 1        F0            F1                  F2                  F3                F4    F5    F6    F7    F8    F9    \<20   \<28   \<30\*   \<150   \<180\*   \<200   \<3.0   \<4.0\*   \<5.0
                                                                               N    28            21                  300                 58                16    0     29    20    24    1     15     81     112      37      80        107     29      72        134
                                                                               \%   5.6           4.2                 60.4                11.7              3.2   0.0   5.8   4.0   4.8   0.2   3.0    16.3   22.5     7.4     16.1      21.5    5.8     14.5      27.0

Age is shown as mean (SD). Asterisks show the predefined cut-off values for vitamin B~1~, vitamin B~12~, and folate (vitamin B~9~) based on a reference ([@B12]); different cut-off values based on previous reports ([@B14]--[@B16]) are also presented for further investigation.

ICD-10 codes (Representative disorders in parentheses). F0, Organic, including symptomatic, mental disorders (e.g., dementia and other mental disorders due to brain damage and dysfunction and to physical disease); F1, Mental and behavioral disorders due to psychoactive substance use (e.g., due to use of alcohol, opioids, cannabinoids, and other substances); F2, Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders (e.g., acute and transient psychotic disorders); F3, Mood disorders (e.g., depressive episode and bipolar affective disorder); F4, Neurotic, stress-related and somatoform disorders (e.g., anxiety, obsessive-compulsive, stress-related, dissociative, somatoform, and other neurotic disorders); F5, Behavioral syndromes associated with physiological disturbances and physical factors (e.g., eating and nonorganic sleep disorders); F6, Disorders of adult personality and behavior (e.g., emotionally unstable personality disorder); F7, Mental retardation (e.g., intellectual disabilities); F8, Disorders of psychological development (e.g., pervasive and specific developmental disorders); F9, Behavioral and emotional disorders with onset usually occurring in childhood and adolescence (e.g., hyperkinetic, conduct, and tic disorders).

###### 

Vitamin B deficiencies in sub-groups.

                    F0              F1              F2              F3              F4              F6              F7              F8              F9
  ----------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------
  vitB~1~ \< 30     9               4               70              11              3               7               5               3               0
  \[ng/mL\]         (32%)           (19%)           (23%)           (19%)           (19%)           (24%)           (25%)           (13%)           
  vitB~12~ \< 180   5               4               53              7               3               1               4               3               0
  \[ng/L\]          (18%)           (19%)           (18%)           (12%)           (19%)           (3%)            (20%)           (13%)           
  Folate \< 4.0     5               7               38              6               5               3               4               4               0
  \[μg/L\]          (18%)           (33%)           (13%)           (10%)           (31%)           (10%)           (20%)           (17%)           
  **Odds ratio**    **F0**          **F1**          **F2**          **F3**          **F4**          **F6**          **F7**          **F8**          **F9**
  vitB~1~ \< 30     1.68            0.80            1.12            0.78            0.79            1.10            1.15            0.48            0
  \[ng/mL\]         \[0.74-3.83\]   \[0.26-2.43\]   \[0.73-1.73\]   \[0.39-1.57\]   \[0.22-2.81\]   \[0.46-2.65\]   \[0.41-3.24\]   \[0.14-1.63\]   
  vitB~12~ \< 180   1.14            1.24            1.35            0.69            1.21            0.18            1.32            0.73            0
  \[ng/L\]          \[0.42-3.10\]   \[0.41-2.43\]   \[0.82-2.23\]   \[0.30-1.58\]   \[0.34-4.35\]   \[0.02-1.31\]   \[0.43-4.05\]   \[0.21-2.52\]   
  Folate \< 4.0     1.30            3.16            0.70            0.65            2.81            0.59            1.32            1.04            0
  \[μg/L\]          \[0.48-3.55\]   \[1.23-8.13\]   \[0.42-1.15\]   \[0.27-1.58\]   \[0.95-8.34\]   \[0.17-1.98\]   \[0.43-4.05\]   \[0.35-3.14\]   

Square brackets indicate the 95% confidence interval.

See [**Table 1**](#T1){ref-type="table"}.

###### 

Summary of full dataset of 29 parameters for machine-learning.

  Parameters   Units       Mean   SD
  ------------ ----------- ------ ------
  WBC          ×10^3^/µL   8.2    2.8
  Hb           g/dL        13.7   1.7
  Hct          \%          40.3   4.5
  MCV          fL          89     6.6
  Plt          ×10^4^/µL   24.9   6.3
  RDW.CV       \%          13.5   1.3
  Neu          \%          70     11
  Lym          \%          23     10
  Mono         \%          6      2
  Eo           \%          1      2
  Baso         \%          0      0
  TP           g/dL        7.2    0.6
  Alb          g/dL        4.4    0.4
  UN           mg/dL       12.9   6.7
  Cre          mg/dL       0.7    0.2
  T.bil        mg/dL       0.7    0.4
  Na           mmol/L      139    3
  Cl           mmol/L      105    4
  K            mmol/L      3.7    0.4
  cor.Ca       mg/dL       9.1    0.5
  CK           IU/L        514    1230
  AST          IU/L        31     34
  ALT          IU/L        27     24
  LDH          IU/L        239    91
  ALP          IU/L        224    81
  γGTP         IU/L        37     63
  Glu          mg/dL       112    40
  CRP          mg/dL       0.4    0.9
  TSH          μIU/mL      1.7    2.4

Two patients lacked age data (no photo ID was available), and one patient lacked biochemistry data (inappropriate sample processing). For machine-learning, the missing values were replaced using the mean.

WBC, white blood cell count; Hb, hemoglobin; Hct, hematocrit; MCV, mean corpuscular volume; RDW.CV, red blood cell distribution width-coefficient variation; Plt, platelet; Neu, neutrocyte fraction; Lym, lymphocyte fraction; Mono, monocyte fraction; Eo, eosinocyte fraction; Baso, basocyte fraction; TP, total protein; Alb, albumin; UN, urea nitrogen; Cre, creatinine; T.bil, total bilirubin; Na, sodium; Cl, chloride; K, potassium; cor.Ca, corrected calcium; CK, creatine kinase; AST, aspartate transaminase; ALT, alanine transaminase; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; γGTP, γ-glutamyltransferase; Glu, plasma glucose; CRP, C-reactive protein; TSH, thyroid-stimulating hormone.

![Histogram and ROC curves of each vitamin B value. **(A--C)** The histograms for vitamin B~1~, vitamin B~12~, and folate (vitamin B~9~). Their medians (1^st^--3^rd^ quartile) are 35 (30--42) ng/mL, 285 (206--431) ng/L, and 7.2 (4.9--10.8) μg/L, respectively. **(D--F)** ROC curves for vitamin B~1~, vitamin B~12~, and folate. Operating points used in [**Table 4**](#T4){ref-type="table"} and [**Supplementary Table 5**](#SM1){ref-type="supplementary-material"} are depicted in blue. Vit B~1~, vitamin B~1~; Vit B~12~, vitamin B~12~.](fpsyt-10-01029-g002){#f2}

Prediction via Machine-Learning Using Routine Blood Test Results {#s3_2}
----------------------------------------------------------------

Machine-learning classifiers were trained to predict the deficiency of each substance from patient characteristics and routine blood test results. The classifiers were trained using the dataset gathered in the period from September 2015 to December 2016 (the "Training set," n = 373), which was then validated from January 2017 through August 2017 (the "Validation set," n = 124). By splitting the whole dataset in this way, the ratio of the training and validation sample size was 3:1, a commonly used ratio in machine-learning analyses.

AUCs for the validation set for each classifier are summarized in [**Table 4**](#T4){ref-type="table"}. Although the performance of the classifiers was similar except for the k-nearest neighbors, random forest yielded the highest AUC on average. Therefore, we focused on random forest in the following analysis.

###### 

Summary of AUC, sensitivity, specificity, and accuracy for the validation set.

  AUC                                                                                                                     
  -------------------------------------------------------------- ------------------ ------------------ ------------------ -------
  k-nearest neighbors                                            0.596              0.542              0.514              0.551
                                                                 \[0.483--0.702\]   \[0.394--0.705\]   \[0.383--0.651\]   
  Logistic regression                                            0.715              0.602              0.754              0.690
                                                                 \[0.602--0.815\]   \[0.454--0.745\]   \[0.610--0.877\]   
  Support vector machine                                         0.715              0.620              0.699              0.678
                                                                 \[0.613--0.814\]   \[0.472--0.763\]   \[0.536--0.842\]   
  Random forest                                                  0.716              0.599              0.796              0.704
                                                                 \[0.610--0.825\]   \[0.426--0.755\]   \[0.656--0.911\]   
  **Sensitivity, specificity, and accuracy for random forest**                                                            
                                                                 **vitB~1~**        **vitB~12~**       **Folate**         
  Sensitivity                                                    0.594              0.316              0.667              
  Specificity                                                    0.783              0.943              0.917              
  Accuracy                                                       0.688              0.629              0.792              
                                                                 \[0.597--0.787\]   \[0.523--0.746\]   \[0.665--0.909\]   

Generalization performance of the classifiers was evaluated using AUC of the validation set for each type of classifiers. For random forest classifiers, sensitivity, specificity, and accuracy of the classification at the optimal operating points that maximized accuracy on the receiver operating characteristic curve of the validation set are also shown (see also [**Figures 2D--F**](#f2){ref-type="fig"}). Accuracy was defined as the average of the sensitivity and specificity. Square brackets indicate the 95% confidence interval. For further information, see [**Figure 2**](#f2){ref-type="fig"} and [**Supplementary Table 5**](#SM1){ref-type="supplementary-material"}.

AUC, area under the receiver operating characteristic curve.

The AUCs of the random forest classifiers were 0.716, 0.599, and 0.796, for vitB~1~, vitB~12~, and folate, respectively ([**Figures 2D--F**](#f2){ref-type="fig"} and [**Table 4**](#T4){ref-type="table"}). With some operative points on the ROC, the sensitivity, specificity, and accuracy for the validation set were calculated ([**Table 4**](#T4){ref-type="table"}. See also [**Supplementary Table 4**](#SM1){ref-type="supplementary-material"} for training set and [**Supplementary Table 5**](#SM1){ref-type="supplementary-material"} for different operating points). The 95% confidence interval (CI) of the AUC and accuracy was quantified using 1000-times bootstrapping. For random forest classifiers, the 95% CI of each value did not include 0.5, except for the AUC of vitB~12~.

[**Figure 3**](#f3){ref-type="fig"} shows the Gini importance (**A--C**) and partial dependency plots (**D--F**) for the eight most important variables for each substance. The results provided further evidence of a relationship between the vitamin B levels and complete blood count while also indicating the hitherto rarely considered, potential association between these vitamins and alkaline phosphatase (ALP) or thyroid stimulating hormone (TSH).

![Gini importance and partial dependence plots of vitamin B deficiencies. The Gini importance **(A--C)** and partial dependency plots of the probability of deficiency **(D--F)** are shown for the eight most important variables for vitamin B~1~, vitamin B~12~, and folate (vitamin B~9~). Combined with these, this machine-learning classifier without hypothesis also provided further evidence of a relationship between vitamin B levels and the complete blood count while also indicating a potential association between these vitamins and alkaline phosphatase (ALP) or thyroid-stimulating hormone (TSH). Vit B~1~, vitamin B~1~; Vit B~12~, vitamin B~12~; Hb, hemoglobin; Hct, hematocrit; WBC, white blood cell count; CK, creatine kinase; RDW.CV, red blood cell distribution width-coefficient variation; Plt, platelet; ALT, alanine transaminase; Lym, lymphocyte fraction; Cre, creatinine; Neu, neutrocyte fraction; γGTP, γ-glutamyltransferase; MCV, mean corpuscular volume; Glu, plasma glucose.](fpsyt-10-01029-g003){#f3}

Robustness Verification {#s3_3}
-----------------------

We verified the robustness of the results by three independent means. First, we asked if the prediction performance was influenced by the ICD-10 categories. When the prediction performances were compared between the random forest classifiers trained using the dataset from the F2 population and the classifiers trained using the dataset from the other population, the AUC was not statistically different (DeLong's test), except in the case of vitB~1~ (see [**Supplementary Table 6**](#SM1){ref-type="supplementary-material"}).

Second, we used different cut-off values to define the deficiency ([@B14]--[@B16]). Although the AUC for the validation set, shown in [**Supplementary Table 7**](#SM1){ref-type="supplementary-material"}, tended to be higher when strict cut-off values were used, the obtained AUCs were not statistically significant (p \> 0.05, DeLong's test with Bonferroni correction).

Third, we investigated if the prediction performance was influenced by the way the dataset was split into the training and validation set. Here, we trained and evaluated random forest classifiers using a dataset split in a reversed way (see *Methods* section for details). The AUCs for the validation set were 0.771, 0.621, and 0.745 for vitB~1~, vitB~12~, and folate, respectively; none were statistically different from the AUC trained using the original setting (DeLong's test), further demonstrating the robustness of the performance.

Subsampling Analysis {#s3_4}
--------------------

To estimate the number needed to saturate the performance, we examined the relationship between the generalizability and the sample size ([@B17]). We randomly sampled X% of the training set, trained random forest classifiers using the dataset, and evaluated the generalization performance by AUCs using the validation set (X = 30, 35, 40, ..., 95, and 100; see Methods for details). As shown in [**Figure 4**](#f4){ref-type="fig"}, the relationships between AUC and the training size for vitB~1~ and vitB~12~ were almost saturated, whereas that for folate is not saturated. To quantitatively understand this, we fitted each curve using a saturating function formulated in equation (1) (see *Methods* section for details). The fitted parameters of equation (1) were as follows; for vitB~1~, a = 0.186 and b = 0.074; for vitB~12~, a = 0.099 and b = 0.156; and for folate, a = 0.291 and b = 0.123. By using these parameter values and extrapolating the curve, we then computed how many additional samples are necessary to reach almost maximum performances. To reach 99% of the maximum performance \[i.e., Y = (a + 0.5) × 0.99 in equation (1)\], the training dataset to be collected was 92.5%, 143%, and 341% of the training size in this study for vitB~1~, vitB~12~, and folate, respectively. These quantitative analyses revealed that collecting further similar datasets up to 1,000 patients (e.g. four years × hospitals with similar scale as Tokyo Metropolitan Tama Medical Center) may increase and reproduce the generalizability for folate, while the effect of collecting further dataset is expected to be small for vitB~1~ and vitB~12~.

![Subsampling analysis. The AUC performances as a function of the dataset size is shown for each vitamin (mean ± SEM across 100 repetitions; see *Methods* for details).](fpsyt-10-01029-g004){#f4}

Discussion {#s4}
==========

Relevance of The Present Study {#s4_1}
------------------------------

Based on the largest cohort to date of patients at imminent risk of seriously harming themselves or others, this study indicated that deficiency of certain vitamins can be predicted in an efficient manner via machine-learning using routine blood test results. The 29 routine blood variables are available at almost all hospitals/clinics and are necessary to rule out other comorbid physical problems. Given the large number of patients with vitamin B deficiencies, empirical therapy might be acceptable; however, risk stratification is preferred for personalized medicine and shared decision-making. The prediction method presented here may expedite clinical decision-making as to whether vitamins should be prescribed to a patient ([**Graphical Abstract**](#f5){ref-type="fig"}).

Remarkably, the AUC of folate deficiency was 0.796. The robustness of folate prediction was also suggested by various independent methods and statistics. Folate has a potential to maintain neuronal integrity and is one of the homocysteine-reducing B-vitamins ([@B5]). Homocysteine may be linked to the etiology of schizophrenia ([@B18]), and vitamin B supplements have been reported to reduce psychiatric symptoms significantly in patients with schizophrenia ([@B7]). A recent meta-review has pointed out that the bioactivity of the supplement should be considered (e.g. methylfolate, which successfully crosses the blood-brain barrier, has been reported effective, whereas the effect of other forms of folate is equivocal) ([@B19]). As our study does not present longitudinal clinical courses, an intervention effect of folate supplementation to the cohort based on our method remains to be clarified.

Biological Mechanism Prediction {#s4_2}
-------------------------------

To connect with biological knowledge, we compared four models with high interpretability in this study. Using the random forest classifiers, as shown in [**Figure 3**](#f3){ref-type="fig"}, we identified several items related to complete blood count as top hits. Notably, our classifier was blind to any biological knowledge, including the well-established association between anemia and vitamin B deficiency, including folate ([@B20]). The results provide further evidence of a relationship between vitamin B levels and the complete blood count and support the use of machine-learning to investigate novel, underlying biological mechanisms ([@B21]).

ALP and its metabolites indicate the vitamin B~6~ status ([@B22]); low vitB~12~ is potentially associated with low ALP ([@B23]). More generally, ALP may have a close and complicated relationship with the overall vitamin B group. Autoimmune disorders, especially thyroid disease, are commonly associated with pernicious anaemia ([@B24]), but there has been no established hypothesis regarding the causal relationships between thyroid disease and vitamin B deficiencies. The potential association between the levels of these vitamins and ALP or TSH awaits further study, both via investigations of populations and basic research ([@B25]).

Limitations {#s4_3}
-----------

This study is subject to several limitations. First, the findings of this single-center retrospective study may have limited external generalizability, though internal generalizability was considered to the maximum extent. Second, the patients' basic characteristics and long-term prognosis were not fully investigated due to administrative restrictions. Though there is similar involuntary treatment/admission in psychiatry worldwide, there is a gap between legislation and practice ([@B26]). Therefore, the extent to which this method can expedite clinical decision-making is unclear.

Further, we did not investigate the relationship between serological values and the need for intervention. The lack of data for vitamin B deficiency in the Japanese general population hampered the comparison between the experimental cohort and their counterparts who lacked psychiatric symptoms. Establishing appropriate reference values and an assessment method requires further investigation. Finally, we did not assess the predictive value of other nutritional impairments, including vitamin B~6~ and homocysteine deficiency, which were previously shown to have a close link with psychiatric symptoms ([@B3], [@B5]); however, our study provides fundamental data on nutritional impairment based on the largest cohort of patients with intense psychiatric episode ever assembled for this purpose and presents a potential framework for predicting nutritional impairment using machine-learning.

Conclusion {#s4_4}
----------

The present report is, to the best of our knowledge, the first to demonstrate that machine-learning can efficiently predict nutritional impairment. This study also provides a possible application of machine-learning to investigate novel, underlying biological mechanisms. Further research is needed to validate the external generalizability of the findings in other clinical situations and clarify whether interventions based on this method can improve patient care and cost-effectiveness.
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